These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Disorders of gut-brain interaction and the long-term risks of opioids. Sahota S; Fortun P Br J Hosp Med (Lond); 2019 Oct; 80(10):C150-C154. PubMed ID: 31589497 [TBL] [Abstract][Full Text] [Related]
23. Control of neuropathic pain by immune cells and opioids. Machelska H CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):559-70. PubMed ID: 21631408 [TBL] [Abstract][Full Text] [Related]
25. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects. Zhang H; Torregrossa MM; Jutkiewicz EM; Shi YG; Rice KC; Woods JH; Watson SJ; Ko MC Eur J Neurosci; 2006 Feb; 23(4):984-94. PubMed ID: 16519663 [TBL] [Abstract][Full Text] [Related]
26. Mu-Opioids Suppress GABAergic Synaptic Transmission onto Orbitofrontal Cortex Pyramidal Neurons with Subregional Selectivity. Lau BK; Ambrose BP; Thomas CS; Qiao M; Borgland SL J Neurosci; 2020 Jul; 40(31):5894-5907. PubMed ID: 32601247 [TBL] [Abstract][Full Text] [Related]
27. Opioid activities of human beta-casomorphins. Koch G; Wiedemann K; Teschemacher H Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):351-4. PubMed ID: 3005882 [TBL] [Abstract][Full Text] [Related]
28. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Kampa M; Bakogeorgou E; Hatzoglou A; Damianaki A; Martin PM; Castanas E Eur J Pharmacol; 1997 Sep; 335(2-3):255-65. PubMed ID: 9369381 [TBL] [Abstract][Full Text] [Related]
30. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
37. Milk A1 and A2 peptides and diabetes. Clemens RA Nestle Nutr Workshop Ser Pediatr Program; 2011; 67():187-95. PubMed ID: 21335999 [TBL] [Abstract][Full Text] [Related]
38. The opioid system and food intake: homeostatic and hedonic mechanisms. Nogueiras R; Romero-Picó A; Vazquez MJ; Novelle MG; López M; Diéguez C Obes Facts; 2012; 5(2):196-207. PubMed ID: 22647302 [TBL] [Abstract][Full Text] [Related]
39. Food matrix and the microbiome: considerations for preclinical chronic disease studies. Ward RE; Benninghoff AD; Hintze KJ Nutr Res; 2020 Jun; 78():1-10. PubMed ID: 32247914 [TBL] [Abstract][Full Text] [Related]
40. Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs. Spano MS; Fadda P; Fratta W; Fattore L Curr Drug Targets; 2010 Apr; 11(4):450-61. PubMed ID: 20017729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]